AxoGen (AXGN) Reports In-Line Q2 EPS

AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $21.26 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI